研究概要
免疫调节是克服肿瘤耐药性的一种有前景的策略。利用天然产物作为免疫调节剂来增强肿瘤化疗敏感性可能构成一种新的治疗策略,为开发新型辅助性癌症疗法提供了基础。
研究思路结论见上方概要
背景
癌症仍然是现代医学中最严峻的挑战之一。化疗耐药,尤其是对铂类药物的耐药,是有效治疗面临的主要难题。针对这一问题,癌症免疫治疗作为一种治疗策略应运而生,通过增强机体免疫系统和细胞防御来消灭癌细胞,补充了癌症治疗的既定支柱:手术、放疗和化疗。近年来,天然产物因其癌症免疫治疗特性以及帮助克服化疗耐药的潜力而引起了广泛关注。然而,其潜在机制仍知之甚少。目的与发现:在本综述中,我们探讨了免疫细胞在肿瘤增殖和清除中的双重作用,并讨论了天然产物在减轻和克服肿瘤耐药性方面的应用,特别聚焦于免疫调节机制。现有证据表明,特定的天然产物可以通过调节T细胞、巨噬细胞、NK细胞和树突状细胞的功能来减轻化疗耐药。值得注意的是,黄芩苷、柚皮苷、人参皂苷和白术内酯I可以通过免疫调节、增强凋亡以及抑制致癌通路(NF-κB、PI3K/Akt、STAT3)来减轻铂类耐药。这些化合物在结直肠癌、肺癌和卵巢癌中显示出协同治疗潜力。
展开英文摘要原文
RATIONALE: Cancer remains one of the most formidable challenges in mordern medicine. Chemoresistance, particularly resistance to platinum-based agents, presents a major challenge in effective treatments. In response to this issue, cancer immunotherapy has emerged as a treatment approach that boosts the body's immune system and cellular defenses to eliminate cancer cells, complementing the established pillars of cancer treatment: surgery, radiotherapy, and chemotherapy. Recently, natural products have attracted significant interest for their cancer immunotherapeutic properties as well as their potential to help overcome chemoresistance. Yet the underlying mechanisms remain poorly understood.
OBJECTIVE AND FINDINGS: In this review, we examine the dual roles of immune cells in tumor proliferation and elimination and discuss the application of natural products in alleviating and overcoming tumor drug resistance, specifically focusing on immunomodulatory mechanisms. Current evidence shows that specific natural products can attenuate chemoresistance by modulating the functions of T cells, macrophages, NK cells, and dendritic cells. Notably, baicalin, naringin, ginsenosides, and atractylenolide I can alleviate platinum resistance via immunomodulation, enhanced apoptosis, and inhibition of oncogenic pathways (NF-κB, PI3K/Akt, STAT3). These compounds show synergistic therapeutic potential in colorectal, lung, and ovarian cancers.
CONCLUSION: Immunomodulation represents a promising strategy in overcoming tumor drug resistance. The use natural products as immunomodulatory agents to enhance tumor chemosensitivity may constitute a novel therapeutic strategy, providing a foundation for the development of novel adjuvant cancer therapies.
论文信息
- 作者
- Zhu Y、Lu E、Li F、Fan Y、Zhang J、Deng L、Li X、Zhang T
- 第一作者单位
- Department of Integration of Chinese and Western Medicine, School of Basic Medical Sciences, Peking University, Beijing, China.China
- 通讯作者单位
- Department of Gynecology, The First Hospital of China Medical University, Shenyang, Liaoning, China.China
- 文献类型
- 综述
- 期刊
- Frontiers in pharmacology2026